When including individual fetal growth at week 28, the adjusted OR attenuated to 1.75 (95% CI, 1.22-2.53) for children of mothers with diet-treated GDM and to 1.51 (95% CI, 0.56-4.10) for children of mothers with insulin-treated GDM. The gene discussed is INS; the disease is gestational diabetes.